Kenya has set 2027 as the target year to begin manufacturing vaccines locally, a move government officials describe as critical to reducing reliance on donor-funded...
TOKYO- Japan The Drugs for Neglected Diseases initiative (DNDi), co-founded by the Kenya Medical Research Institute (KEMRI), has been awarded the Hideyo Noguchi Africa Prize...
Kenya is turning to local manufacturing and strategic partnerships to drive its journey toward sustainable healthcare and Universal Health Coverage (UHC). At the Ninth Tokyo...
TOKYO-Japan Kenya has reported significant progress in tackling some of its most pressing public health challenges, with the latest data showing major improvements in the...
A new infant-friendly malaria drug, artemether-lumefantrine, has been approved in Kenya, offering safe treatment for newborns under five kilograms who previously had none. Developed through...
The Ministry of Health’s Pharmacy and Poisons Board (PPB) has issued a safety alert cautioning Kenyans against the misuse of semaglutide-containing medicines, such as Ozempic,...